The Valley Desk

NCT04338269 · Interventional trial

A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment

Overall registry status Terminated

Phase 3

Conditions Carcinoma, Renal Cell

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov